drugset / Trial / NCT06553898
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
NaSingle-groupOpen-labelTreatment
Summary
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-BCMA/CD70 CAR-T cells in the treatment of patients with Multi-drug resistant SRNS
Timeline
- Start
- 2024-08-13
- Primary completion
- 2026-07-31
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | anti-BCMA/CD70 CAR-T cells | Cell therapy | 30000 cells/kg | — |
| Subject | anti-BCMA/CD70 CAR-T cells | Cell therapy | 100000 cells/kg | — |
| Subject | anti-BCMA/CD70 CAR-T cells | Cell therapy | 300000 cells/kg | — |